Filana Therapeutics
FLNA
62 hedge funds and large institutions have $115M invested in Filana Therapeutics in 2013 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 16 closing their positions.
289% more call options, than puts
Call options by funds: $447K | Put options by funds: $115K
72% more capital invested
Capital invested by funds: $67.2M → $115M (+$48.2M)
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
2% more funds holding
Funds holding: 61 → 62 (+1)
6% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 16
0% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Sophrosyne Capital
New York
|
+$3.22M |
| 2 |
First Eagle Investment Management
New York
|
+$1.88M |
| 3 |
ICMC
Intrepid Capital Management (Connecticut)
Greenwich,
Connecticut
|
+$1.74M |
| 4 |
BC
Broadfin Capital
New York
|
+$872K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$803K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$6.41M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$1.87M |
| 3 |
Renaissance Technologies
New York
|
-$1.59M |
| 4 |
Goldman Sachs
New York
|
-$499K |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$429K |
FLNA Hedge Fund Activity: Q4 2013 in Review
62 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q4 2013, worth a combined $115M — up 72% from $67.2M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new FLNA positions and 16 closed out — a net gain of 1 holder — while 18 added to existing stakes and 18 trimmed.
The largest buyer was Sophrosyne Capital, adding an estimated $3.22M. The largest seller was BVF Inc, exiting entirely with an estimated $6.41M sold.
- 62 institutional investors held Filana Therapeutics (FLNA) as of Q4 2013, up from 61 in Q3 2013.
- Funds reported $115M of Filana Therapeutics stock for Q4 2013, up 72% quarter-over-quarter.
- 17 funds opened new Filana Therapeutics positions in Q4 2013 and 16 closed out, a net change of +1 holder.
- The largest Filana Therapeutics buyer in Q4 2013 was Sophrosyne Capital, an estimated $3.22M added.
- The largest Filana Therapeutics seller in Q4 2013 was BVF Inc, an estimated $6.41M sold.
Based on aggregated 13F filings for Q4 2013.